FDA Investigator Kimberly Cdelk Brooks

Kimberly Cdelk Brooks has conducted inspections on 142 sites in 1 countries as of 31 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
142
Last Inspection Date:
31 May 2024
Investigator Role:
FDA Investigator
Redica ID:
100005653
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Kimberly Cdelk Brooks:
Aaron P Wozniak, Abdur Rashid, Adam J Williams, Aliza Chalapong Asawesna, Alphonso A Haupt, III, Amanda L Evanco, Amy A Johnson, Andrea Ab Bautista, Annette Melendez, April R Bowen, Arthur G Hurst, Babatunde D Babalola, Barbara D Wright, Barbara T Carmichael, Bonita S Chester, Brandon C Heitmeier, Brandon L Mariner, Brandy D Brown, Brentley S Collins, Brian A Graves, Brian R Yaun, Brian S Lynch, Bryan G Hills, Calvin Foulks, Cara M Minelli, Carl E Lovrich, Carlos A Ortiz, Carmen Y Fisher, Carol F Robinson, Carol J Blackwood, Chateryl K Washington, Cherie T Parker, Cheryl D Barton, Christie A Soto, Christina H Owens, Christopher J Adams, Claudele S Razo, Claudette D Brooks, Cody D Rickman, Collins M Mason, Cordelia J Brammer, Dan My Chu, Danielle Lyke, Danielle M Maddox, Davia K Arnold, David A Faranda, David A Keith, Jr, David E Lowe, David T Glover, Davis, Dawn M Braswell, Debra J Tucker, Dellarese L Herbert, Derek C Price, Diana M Guidry, Diana M Raman, Donna D Gallien, MPH, Doretha M Tonkins, Edecia A Richards, Edward Deberry, Eileen J Bannerman, Ele Ibarra Pratt, RN, MPH, Elenita Yibarra Pratt, Elizabeth R Pepinsky, Emil P Wang, JD, Emily A Walters, Emily E Smith, Emily S Mcgann, Erik T Nagaoka, Erika M Wilkerson, Ernest H Blackwood, Esra Toussaint, Fabian Nchaparro Rodriguez, Fulton A Varner, Gabriel E Muniz, Gabriel Muniz, Gabriel R Mclemore, Gamal A Norton, Garrad R Poole, Gary E Coleman, Jr, REHS, Gates E Raynor, Hai Lient Phung, Helen R Bester, Hristu B Chepa, Ibad U Khan, Inga M Warr, James C Maclaughlin, Janet B Gray, Jannet M Peroti, Jason D Tenney, Jawaid Hamid, Jessica A Stephens, Jessica Fields, John D Lloyd, Johnson, Joseph F Owens, Juanelma H Palmer, Judy Ellen Ciaraldi, Justin A Hefferman, Karen A Coleman, Kathleen D Culver, Kenneth L Smalls, Kenneth R Merritt, Kenny R Robinson, Keri U Walker, Kimberley A Hoefen, Kip J Hanks, Konsuela Y Glass, Laressa R Gray, Latonya T Jiggetts, Laura D Cain, Lauren E Ciurca, Lawrence Thomas, LCDR Audra J Lenhart, LCDR Matthew R Mcnew, MPH, REHS/RS, Leena Thomas, Leslie W Gilbert, Lisa Shin, Lorenzo Jones, Mallory M Bowling, Marcella D Crook, Marian A Kainer, Marla A Cassidy, Marvin D Jones, Mary A Millner, Mary Alice Papadimitriou, Mary T Carden, Matthew G Brown, Melanie M Walker, Melanie W Pishnery, Miaja Umaedi, Michael Gu, Michael M Quinn, Michelle D Haamid, Michelle L Jones, Mokhless A Ghaly, Myla D Chapman, Myoshi M Francis, N'jere English, Nancy E Fontaine, Natasha N Livingston, Nicholas M Smith, Pamela L Velez Vega, Patricia F Hudson, Paul A Bonneau, Paul Perdue (NMI), Jr, Paula J Bretz, Randy L Clarida, Rhonda Alexander, Richard J Bashay, Richard L Garcia, Robert C Coleman, Robert J Rutherford, Robert Q Green, Ronnie E Jackson, Russell R Zablan, S Alexander Hamblin, Sally Gopaul, Samuel A Hamblin, Sandra C Lawrence, Sandra I Gaul, Sarah C Pichette, Sayeeda Hdabe, Scott T Ballard, Seneca D Toms, Shayla G Turnipseed, Shelton L Stribling, Sheri L Stephenson, Sheri S Oliver, Sondra R Davis, Stardust W Mazzariello, Stephanie E Hubbard, Stephanie Harrell, Steven D Banks, Susan O Oladeji, Swati A Kabaria, Tamika D Cathey, Tammara A Stephens, Thao Le, Thomas D Clarida, Thomas J Prigge, Thomas R Stanley, Tracy A Holloman, Tracy R Ball, Trang N Cox, Trang P Nguyen, Tyrico K English, Vanessa E Coulter, Verdell Nelson, Veronica Fuentes, MS, Vicky C Stoakes, Vincent M Williams, Wayne S Fortenberry, William P Tonkins, Xiomara Copeland, Young Kim

Kimberly Cdelk Brooks's Documents

Publish Date Document Type Title
February, 2016 FDA 483 MiMedx Group, Inc. - Form 483, 2016-02-04
December, 2011 EIR American Red Cross Blood Services - EIR, 2011-12-02
March, 2014 FDA 483 Artivion, Inc - Form 483, 2014-03-20
July, 2016 EIR NASCO Products LLC - EIR, 2016-07-07
February, 2016 FDA 483 Response MiMedx Group, Inc. - Form 483R, 2016-02-25
January, 2012 EIR Vector Tobacco, LLC - EIR, 2012-01-26
August, 2016 EIR R. J. Reynolds Tobacco Company - EIR, 2016-08-19
September, 2010 FDA 483 LifeSouth Community Blood Centers, Inc. - Form 483, 2010-09-10
May, 2011 EIR American Red Cross Blood Svcs - EIR, 2011-05-05
January, 2014 EIR The American National Red Cross American Red Cross Blood Services Southern Region - EIR, 2014-01-24
January, 2012 EIR Liggett Group, LLC - EIR, 2012-01-26
March, 2014 FDA 483 Response Artivion, Inc - Form 483R, 2014-04-10
July, 2012 EIR C.R. BARD, INC. - EIR, 2012-07-25
October, 2012 FDA 483 Artivion, Inc - Form 483, 2012-10-16
June, 2016 EIR R.J. Reynolds Tobacco Company - EIR, 2016-06-21
June, 2013 EIR The American National Red Cross - Southern Region - EIR, 2013-06-21
October, 2013 EIR American Red Cross Blood Services - EIR, 2013-10-24
February, 2016 EIR MiMedx Group, Inc. - EIR, 2016-02-04
May, 2017 EIR Philip Morris USA - EIR, 2017-05-11
June, 2012 EIR The American National Red Cross - Southern Region - EIR, 2012-06-29
July, 2012 FDA 483 C.R. BARD, INC. - Form 483, 2012-07-25
October, 2011 EIR Cheyenne International, LLC - EIR, 2011-10-13
November, 2012 EIR American Red Cross - EIR, 2012-11-16

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more